Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHE.L Regulatory News (GHE)

  • There is currently no data for GHE

Form 8.3 - Gresham House plc

27 Jul 2023 11:43

RNS Number : 4386H
Gresham House PLC
27 July 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Colin Lees-Millais

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Gresham House plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26th July 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

449,142

1.17%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

449,142

1.17%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

27th July 2023

Contact name:

Colin Lees-Millais

Telephone number*:

+44 (0) 1451 844 655

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBDLFLXDLXBBL
Date   Source Headline
21st Jun 202110:54 amRNSDirector/PDMR Shareholding
15th Jun 20213:36 pmRNSUpdate on reduction of capital
7th Jun 20217:00 amRNSDirector/PDMR Shareholding
3rd Jun 20214:26 pmRNSUpdate on reduction of capital
27th May 20217:00 amRNSDirector/PDMR Shareholding
25th May 20212:53 pmRNSGM Requisition and Fund Manager update
24th May 20217:00 amRNSPDMR Dealings
14th May 20217:05 amRNSInvestment in Strategic Equity Capital
14th May 20217:00 amRNSNotification of Major Holdings
12th May 20214:18 pmRNSResults of Annual General Meeting
12th May 20217:00 amRNSAGM Statement
13th Apr 20217:00 amRNSPosting of Report and Accounts and Notice of AGM
31st Mar 20213:44 pmRNSNotification of Major Holdings
30th Mar 20217:00 amRNSNotification of Major Holdings
23rd Mar 20217:00 amRNSIssue of Shares to Employee Benefit Trust
16th Mar 20215:50 pmRNSDividend Timetable
11th Mar 20217:00 amRNSAnnual Results for the year ended 31 December 2020
2nd Mar 20217:00 amRNSHolding(s) in Company
8th Feb 20219:25 amRNSHolding(s) in Company
4th Feb 20213:43 pmRNS2018 Bonus Share Matching Plan & PDMR Updates
3rd Feb 202112:28 pmRNSDirector/PDMR Shareholding
29th Jan 20214:42 pmRNSPerformance Share Plan Awards
28th Jan 20217:00 amRNSTrading Update
14th Jan 20217:00 amRNSNotification of Major Holdings
24th Dec 20207:00 amRNSGrant of share awards to PDMR
17th Dec 20207:00 amRNSAcquisition of Appian Asset Management Limited
7th Dec 20205:16 pmRNSHolding(s) in Company
2nd Nov 20207:00 amRNSSale of 50MW grid level battery storage project
19th Oct 20208:44 amRNSPDMR Shareholdings
17th Sep 20207:00 amRNSInterim Results
6th Aug 20205:23 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSNotification of Major Holdings
28th Jul 20207:00 amRNSShare issuance to EBT and ESS Exercises by PDMRs
16th Jul 20207:00 amRNSTrading update – First half AUM growth of +17%
6th Jul 20209:34 amRNSIssue of Shares to Employee Benefit Trust
11th Jun 20207:00 amRNSExercise of Put Options and PDMR notification
15th May 20202:05 pmRNSResults of Annual General Meeting
15th May 20207:00 amRNSAGM Statement and Trading Update
15th May 20207:00 amRNSGresham House Appointed Investment Manager to SEC
14th May 20207:00 amRNSAnnual General Meeting Arrangements
7th May 20207:00 amRNSCorporate webinar
20th Apr 20203:50 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 202011:07 amRNSDividend Timetable
15th Apr 20207:00 amRNSNotification of major holdings
8th Apr 20205:53 pmRNSDirector / PDMR Shareholding
27th Mar 20207:00 amRNSNew Contract: Strategic Equity Capital plc
24th Mar 20201:53 pmRNSHolding(s) in Company
23rd Mar 20208:05 amRNSHolding(s) in Company
19th Mar 20201:00 pmRNSHolding(s) in Company
16th Mar 20204:26 pmRNSPlacing of 1,568,628 ordinary shares for cash

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.